Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 1
2003 1
2004 1
2006 1
2007 2
2008 2
2009 3
2010 5
2011 3
2012 2
2013 2
2014 7
2015 7
2016 4
2017 5
2018 9
2019 5
2020 23
2021 17
2022 14
2023 7
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Reprogramming tumour-associated macrophages to outcompete cancer cells.
Zhang X, Li S, Malik I, Do MH, Ji L, Chou C, Shi W, Capistrano KJ, Zhang J, Hsu TW, Nixon BG, Xu K, Wang X, Ballabio A, Schmidt LS, Linehan WM, Li MO. Zhang X, et al. Among authors: do mh. Nature. 2023 Jul;619(7970):616-623. doi: 10.1038/s41586-023-06256-5. Epub 2023 Jun 28. Nature. 2023. PMID: 37380769 Free PMC article.
Programme of self-reactive innate-like T cell-mediated cancer immunity.
Chou C, Zhang X, Krishna C, Nixon BG, Dadi S, Capistrano KJ, Kansler ER, Steele M, Han J, Shyu A, Zhang J, Stamatiades EG, Liu M, Li S, Do MH, Edwards C, Kang DS, Chen CT, Wei IH, Pappou EP, Weiser MR, Garcia-Aguilar J, Smith JJ, Leslie CS, Li MO. Chou C, et al. Among authors: do mh. Nature. 2022 May;605(7908):139-145. doi: 10.1038/s41586-022-04632-1. Epub 2022 Apr 20. Nature. 2022. PMID: 35444279 Free PMC article.
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis.
Do MH, Shi W, Ji L, Ladewig E, Zhang X, Srivastava RM, Capistrano KJ, Edwards C, Malik I, Nixon BG, Stamatiades EG, Liu M, Li S, Li P, Chou C, Xu K, Hsu TW, Wang X, Chan TA, Leslie CS, Li MO. Do MH, et al. Immunity. 2023 Nov 14;56(11):2555-2569.e5. doi: 10.1016/j.immuni.2023.10.010. Immunity. 2023. PMID: 37967531 Free PMC article.
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.
Li S, Liu M, Do MH, Chou C, Stamatiades EG, Nixon BG, Shi W, Zhang X, Li P, Gao S, Capistrano KJ, Xu H, Cheung NV, Li MO. Li S, et al. Among authors: do mh. Nature. 2020 Nov;587(7832):121-125. doi: 10.1038/s41586-020-2850-3. Epub 2020 Oct 21. Nature. 2020. PMID: 33087933 Free PMC article.
Immune checkpoint inhibitors to treat cutaneous malignancies.
Barrios DM, Do MH, Phillips GS, Postow MA, Akaike T, Nghiem P, Lacouture ME. Barrios DM, et al. Among authors: do mh. J Am Acad Dermatol. 2020 Nov;83(5):1239-1253. doi: 10.1016/j.jaad.2020.03.131. Epub 2020 May 24. J Am Acad Dermatol. 2020. PMID: 32461079 Free PMC article. Review.
TGF-β suppresses type 2 immunity to cancer.
Liu M, Kuo F, Capistrano KJ, Kang D, Nixon BG, Shi W, Chou C, Do MH, Stamatiades EG, Gao S, Li S, Chen Y, Hsieh JJ, Hakimi AA, Taniuchi I, Chan TA, Li MO. Liu M, et al. Among authors: do mh. Nature. 2020 Nov;587(7832):115-120. doi: 10.1038/s41586-020-2836-1. Epub 2020 Oct 21. Nature. 2020. PMID: 33087928 Free PMC article.
114 results